Anavex Life Sciences Corp (AVXL)

[Rubyred77]

I’ll entertain Kunds griping about pill labeling for a second.

Comparing recently approved vs not approved AD therapy.

Let’s label everything that we know of as required, for said therapy, with their ticker.

Let’s forget about cost difference for the insurance companies.

Let’s forget about the total opposite side of the spectrum side effects each had.

Let’s even forget about total time wasted, for patients, to be on each therapy and required visits.

That pill is a powerful message for those who know.

When Anavex finally reveals their cards, I’d not be surprised at all that it’ll beat MABs in a line for line comparison.

Que the peer review